{"transactions":[{"id":731839,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T23:05:18.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":31566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":31566,"derivative":{"exercise_price":3.03,"expiration_date":"2036-06-15","underlying":"Common stock","underlying_shares":31566},"source":{"system":"sec-edgar","filing":"0001493152-26-029418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029418/ownership.xml","form_type":"4"}},{"id":731838,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T23:05:18.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":28409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":96483,"source":{"system":"sec-edgar","filing":"0001493152-26-029418","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029418/ownership.xml","form_type":"4"}},{"id":1052712,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:49.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":28576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":28576,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":28576},"source":{"system":"sec-edgar","filing":"0001641172-25-026006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026006/ownership.xml","form_type":"4"}},{"id":1052711,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T20:30:49.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":22283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":68074,"source":{"system":"sec-edgar","filing":"0001641172-25-026006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026006/ownership.xml","form_type":"4"}},{"id":1319702,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy)","published_at":"2024-12-31T18:20:05.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":50469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":50469,"derivative":{"exercise_price":1.96,"expiration_date":"2034-07-31","underlying":"Common Stock","underlying_shares":50469},"source":{"system":"sec-edgar","filing":"0001415889-24-030274","document":"form4a-12312024_011201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924030274/form4a-12312024_011201.xml","form_type":"4/A","original_submission_date":"2024-08-05"}},{"id":1320359,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-31T00:48:31.000Z","date":"2024-12-30","kind":"sale","planned":false,"acquired":false,"shares":3460,"price":2.46,"value":8511.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price for the transaction reported was $2.46, and the range of prices were between $2.45 and $2.46. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":45791,"source":{"system":"sec-edgar","filing":"0001415889-24-030248","document":"form4-12312024_121226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924030248/form4-12312024_121226.xml","form_type":"4"}},{"id":1408472,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T00:40:50.000Z","date":"2024-09-11","kind":"sale","planned":true,"acquired":false,"shares":1730,"price":2.6005,"value":4498.865,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.6005, and the range of prices were between $2.50 and $2.68. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided"}],"balance_after":47521,"source":{"system":"sec-edgar","filing":"0001415889-24-023335","document":"form4-09132024_120946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924023335/form4-09132024_120946.xml","form_type":"4"}},{"id":1440559,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy)","published_at":"2024-08-05T22:37:02.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":50469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":50469,"derivative":{"exercise_price":1.54,"expiration_date":"2034-07-31","underlying":"Common Stock","underlying_shares":50469},"source":{"system":"sec-edgar","filing":"0001415889-24-020781","document":"form4-08052024_100857.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924020781/form4-08052024_100857.xml","form_type":"4"}},{"id":1440558,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T22:37:02.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":39541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":49251,"source":{"system":"sec-edgar","filing":"0001415889-24-020781","document":"form4-08052024_100857.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924020781/form4-08052024_100857.xml","form_type":"4"}},{"id":1486439,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant (Right to Buy)","published_at":"2024-06-08T01:45:20.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's purchase reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of common stock on December 13, 2023.  The Reporting Person has agreed to pay to the Issuer the profit realized in connection with the short-swing transaction, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock.  The combined price of each share of common stock offered together with one warrant was $4.00."}],"balance_after":6250,"derivative":{"exercise_price":5.25,"exercise_date":"2024-05-29","expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001415889-24-016110","document":"form4-06072024_090616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924016110/form4-06072024_090616.xml","form_type":"4"}},{"id":1486438,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-08T01:45:20.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's purchase reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of common stock on December 13, 2023.  The Reporting Person has agreed to pay to the Issuer the profit realized in connection with the short-swing transaction, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock.  The combined price of each share of common stock offered together with one warrant was $4.00."}],"balance_after":9710,"source":{"system":"sec-edgar","filing":"0001415889-24-016110","document":"form4-06072024_090616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924016110/form4-06072024_090616.xml","form_type":"4"}},{"id":1574866,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-16T00:01:14.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":10251,"price":1.1182,"value":11462.6682,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on March 14, 2024 at prices ranging from $1.08 to $1.15 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price."}],"balance_after":188251,"source":{"system":"sec-edgar","filing":"0001104659-24-035117","document":"tm248884-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924035117/tm248884-1_4seq1.xml","form_type":"4"}},{"id":1710790,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T01:59:42.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":3347,"price":13.7327,"value":45963.3469,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $13.7327, and the range of prices were between $13.33 and $14.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":3460,"source":{"system":"sec-edgar","filing":"0001209191-23-058710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123058710/doc4.xml","form_type":"4"}},{"id":1710789,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T01:59:42.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":5653,"price":12.9145,"value":73005.6685,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price for the transaction reported was $12.9145, and the range of prices were between $12.29 and $13.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":6807,"source":{"system":"sec-edgar","filing":"0001209191-23-058710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123058710/doc4.xml","form_type":"4"}},{"id":1781901,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-14T00:16:43.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":4397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":4397,"derivative":{"exercise_price":22.4,"expiration_date":"2033-09-10","underlying":"Common Stock","underlying_shares":4397},"source":{"system":"sec-edgar","filing":"0001209191-23-049367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049367/doc4.xml","form_type":"4"}},{"id":1781900,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-14T00:16:43.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":3460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of common stock upon vesting.  The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":12460,"source":{"system":"sec-edgar","filing":"0001209191-23-049367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049367/doc4.xml","form_type":"4"}},{"id":1895191,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-12T22:34:38.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":3821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Options that vest in full on the first anniversary of the grant date and which were granted on the date of the Issuer's 2023 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":3821,"derivative":{"exercise_price":7.55,"expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":3821},"source":{"system":"sec-edgar","filing":"0001808665-23-000035","document":"wf-form4_168393086569823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866523000035/wf-form4_168393086569823.xml","form_type":"4"}},{"id":1895190,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-12T22:34:38.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":31194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on the first anniversary of the grant date and which were granted on the date of the Issuer's 2023 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":198502,"source":{"system":"sec-edgar","filing":"0001808665-23-000035","document":"wf-form4_168393086569823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866523000035/wf-form4_168393086569823.xml","form_type":"4"}},{"id":1902949,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-06T01:10:58.000Z","date":"2023-05-05","kind":"sale","planned":true,"acquired":false,"shares":43143,"price":5.9979,"value":258767.3997,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2023 to cover taxes upon the May 4, 2023 vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on May 5, 2023 at prices ranging from $5.88 to $6.13 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price."}],"balance_after":167308,"source":{"system":"sec-edgar","filing":"0001808665-23-000020","document":"wf-form4_168333544363685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866523000020/wf-form4_168333544363685.xml","form_type":"4"}},{"id":1908089,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T20:33:07.000Z","date":"2023-02-17","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of common stock upon vesting.  The RSUs will be fully vested on July 25, 2023."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-23-026524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123026524/doc4.xml","form_type":"4"}},{"id":2132857,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-10-24T23:02:45.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":15723,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15723},"source":{"system":"sec-edgar","filing":"0000899243-22-034077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000089924322034077/doc4.xml","form_type":"4"}},{"id":2132856,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-10-24T23:02:45.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":13.94,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-22-034077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000089924322034077/doc4.xml","form_type":"4"}},{"id":2132855,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-10-24T23:02:45.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":13352,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":12.94,"underlying":"Common Stock","underlying_shares":13352},"source":{"system":"sec-edgar","filing":"0000899243-22-034077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000089924322034077/doc4.xml","form_type":"4"}},{"id":2132854,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-10-24T23:02:45.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":12287,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":11.6,"underlying":"Common Stock","underlying_shares":12287},"source":{"system":"sec-edgar","filing":"0000899243-22-034077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000089924322034077/doc4.xml","form_type":"4"}},{"id":2132853,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-10-24T23:02:45.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":4504,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":10.06,"underlying":"Common Stock","underlying_shares":4504},"source":{"system":"sec-edgar","filing":"0000899243-22-034077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000089924322034077/doc4.xml","form_type":"4"}},{"id":2132852,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-10-24T23:02:45.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":8342,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company (\"Company Option\") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":22.39,"underlying":"Common Stock","underlying_shares":8342},"source":{"system":"sec-edgar","filing":"0000899243-22-034077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000089924322034077/doc4.xml","form_type":"4"}},{"id":2132851,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-24T23:02:45.000Z","date":"2022-10-20","kind":"disposition_to_issuer","acquired":false,"shares":9138,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of securities pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 3, 2022, among Amgen Inc. (\"Parent\"), Carnation Merger Sub, Inc. (\"Merger Sub\") and ChemoCentryx, Inc. (the \"Company\"), pursuant to which, on October 20, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the \"Shares,\" and each such share, a \"Share\") (other than any such Shares (i) held by the Company as treasury stock or owned by Parent or Merger Sub, (ii) held by any subsidiary of the Company or Parent (other than Merger Sub) or (iii) as to which appraisal rights have been properly exercised,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) and not withdrawn, in accordance with the Delaware General Corporation Law) was thereupon canceled and converted into the right to receive $52.00 in cash, without interest (the \"Merger Consideration\"). As a result of the Merger, the Reporting Person no longer beneficially owns, directly or indirectly, any Shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-034077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000089924322034077/doc4.xml","form_type":"4"}},{"id":2191777,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-08T23:27:05.000Z","date":"2022-08-04","kind":"sale","acquired":false,"shares":10000,"price":50.22,"value":502200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":9138,"source":{"system":"sec-edgar","filing":"0001209191-22-044891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919122044891/doc4.xml","form_type":"4"}},{"id":2233809,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T22:28:00.000Z","date":"2022-06-09","kind":"sale","acquired":false,"shares":59,"price":26.22,"value":1546.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":19138,"source":{"system":"sec-edgar","filing":"0001209191-22-036438","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919122036438/doc4.xml","form_type":"4"}},{"id":2233808,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T22:28:00.000Z","date":"2022-06-09","kind":"sale","acquired":false,"shares":3804,"price":25.6526,"value":97582.4904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $25.15 to $26.13 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":19197,"source":{"system":"sec-edgar","filing":"0001209191-22-036438","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919122036438/doc4.xml","form_type":"4"}},{"id":2251016,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-01T01:39:15.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":8342,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option granted on May 26, 2022, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date."}],"balance_after":8342,"derivative":{"exercise_price":22.39,"exercise_date":"2023-05-26","expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":8342},"source":{"system":"sec-edgar","filing":"0001209191-22-033045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919122033045/doc4.xml","form_type":"4"}},{"id":2251015,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T01:39:15.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":15723,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units awarded on May 26, 2022, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units awarded on May 26, 2022, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."}],"balance_after":15723,"derivative":{"underlying":"Common Stock","underlying_shares":15723},"source":{"system":"sec-edgar","filing":"0001209191-22-033045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919122033045/doc4.xml","form_type":"4"}},{"id":2257885,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-25T00:18:37.000Z","date":"2022-05-20","kind":"exercise","acquired":false,"shares":7726,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units vested on May 20, 2022.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units vested on May 20, 2022.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7726},"source":{"system":"sec-edgar","filing":"0001209191-22-031763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919122031763/doc4.xml","form_type":"4"}},{"id":2257884,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T00:18:37.000Z","date":"2022-05-20","kind":"exercise","acquired":true,"shares":7726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired upon vesting of restricted stock units awarded on May 20, 2021."}],"balance_after":23001,"source":{"system":"sec-edgar","filing":"0001209191-22-031763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919122031763/doc4.xml","form_type":"4"}},{"id":2270484,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T23:20:27.000Z","date":"2022-05-12","kind":"sale","acquired":false,"shares":44643,"price":2.3558,"value":105169.9794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 28, 2022 to cover taxes upon the May 11, 2022 vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on May 12, 2022 at prices ranging from $2.19 to $2.53 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price."}],"balance_after":210451,"source":{"system":"sec-edgar","filing":"0001808665-22-000039","document":"wf-form4_165274321184427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866522000039/wf-form4_165274321184427.xml","form_type":"4"}},{"id":2279405,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-07T00:27:44.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":86286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on the first anniversary of the grant date and which were granted on the date of the Issuer's 2022 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On May 18, 2021 the Issuer effected a 1-for-4 reverse stock split (the \"Reverse Stock Split\"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":255094,"source":{"system":"sec-edgar","filing":"0001808665-22-000022","document":"wf-form4_165188324747429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866522000022/wf-form4_165188324747429.xml","form_type":"4"}},{"id":2462221,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-21T23:33:13.000Z","date":"2021-12-17","kind":"exercise","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of December 17, 2021, and prior to this transaction, the exercised options were fully vested."}],"balance_after":0,"derivative":{"exercise_price":14.42,"expiration_date":"2022-06-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-070839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121070839/doc4.xml","form_type":"4"}},{"id":2462220,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-21T23:33:13.000Z","date":"2021-12-17","kind":"exercise","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As of December 17, 2021, and prior to this transaction, the exercised options were fully vested."}],"balance_after":0,"derivative":{"exercise_price":12.62,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-070839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121070839/doc4.xml","form_type":"4"}},{"id":2462219,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T23:33:13.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":18066,"price":35.504,"value":641415.264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $35.15 to $35.90 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":15275,"source":{"system":"sec-edgar","filing":"0001209191-21-070839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121070839/doc4.xml","form_type":"4"}},{"id":2462218,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T23:33:13.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":16634,"price":34.7417,"value":577893.4378,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $34.15 to $35.14 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":33341,"source":{"system":"sec-edgar","filing":"0001209191-21-070839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121070839/doc4.xml","form_type":"4"}},{"id":2462217,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T23:33:13.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":2800,"price":33.52,"value":93856.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $33.14 to $34.09 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":49975,"source":{"system":"sec-edgar","filing":"0001209191-21-070839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121070839/doc4.xml","form_type":"4"}},{"id":2462216,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T23:33:13.000Z","date":"2021-12-17","kind":"exercise","acquired":true,"shares":12500,"price":14.42,"value":180250.0,"ownership":{"direct":true},"balance_after":52775,"source":{"system":"sec-edgar","filing":"0001209191-21-070839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121070839/doc4.xml","form_type":"4"}},{"id":2462215,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T23:33:13.000Z","date":"2021-12-17","kind":"exercise","acquired":true,"shares":25000,"price":12.62,"value":315500.0,"ownership":{"direct":true},"balance_after":40275,"source":{"system":"sec-edgar","filing":"0001209191-21-070839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121070839/doc4.xml","form_type":"4"}},{"id":2698439,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-25T00:19:39.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":4660,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"100% of the restricted stock units vested on May 21, 2021.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"100% of the restricted stock units vested on May 21, 2021.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4660},"source":{"system":"sec-edgar","filing":"0001209191-21-035562","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121035562/doc4.xml","form_type":"4"}},{"id":2698438,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-25T00:19:39.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":4504,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option granted on May 20, 2021, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date."}],"balance_after":4504,"derivative":{"exercise_price":10.06,"exercise_date":"2022-05-20","expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":4504},"source":{"system":"sec-edgar","filing":"0001209191-21-035562","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121035562/doc4.xml","form_type":"4"}},{"id":2698437,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-25T00:19:39.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":7726,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units awarded on May 20, 2021, vests on the first anniversary of the  grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units awarded on May 20, 2021, vests on the first anniversary of the  grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":7726,"derivative":{"underlying":"Common Stock","underlying_shares":7726},"source":{"system":"sec-edgar","filing":"0001209191-21-035562","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121035562/doc4.xml","form_type":"4"}},{"id":2698436,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-25T00:19:39.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":2454,"price":9.762,"value":23955.948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover anticipated taxes due upon vesting of restricted stock unit shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.65 to $10.03 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":15275,"source":{"system":"sec-edgar","filing":"0001209191-21-035562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121035562/doc4.xml","form_type":"4"}},{"id":2698435,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-25T00:19:39.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":4660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired upon vesting of restricted stock units awarded on May 21, 2020."}],"balance_after":17729,"source":{"system":"sec-edgar","filing":"0001209191-21-035562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919121035562/doc4.xml","form_type":"4"}},{"id":2714664,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T21:27:04.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":357143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on the first anniversary of the grant date."}],"balance_after":675233,"source":{"system":"sec-edgar","filing":"0001808665-21-000047","document":"wf-form4_162094119519688.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866521000047/wf-form4_162094119519688.xml","form_type":"4"}},{"id":3134858,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-27T00:59:43.000Z","date":"2020-05-23","kind":"exercise","acquired":false,"shares":7724,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the restricted stock units vested on May 23, 2020.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"100% of the restricted stock units vested on May 23, 2020.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7724},"source":{"system":"sec-edgar","filing":"0001209191-20-032212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919120032212/doc4.xml","form_type":"4"}},{"id":3134857,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-27T00:59:43.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":4660,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units awarded on May 21, 2020, vests on the first anniversary of the  grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units awarded on May 21, 2020, vests on the first anniversary of the  grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":4660,"derivative":{"underlying":"Common Stock","underlying_shares":4660},"source":{"system":"sec-edgar","filing":"0001209191-20-032212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919120032212/doc4.xml","form_type":"4"}},{"id":3134856,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-27T00:59:43.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":2888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option granted on May 21, 2020, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date."}],"balance_after":2888,"derivative":{"exercise_price":59.73,"exercise_date":"2021-05-21","expiration_date":"2030-05-21","underlying":"Common Stock","underlying_shares":2888},"source":{"system":"sec-edgar","filing":"0001209191-20-032212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919120032212/doc4.xml","form_type":"4"}},{"id":3134855,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-27T00:59:43.000Z","date":"2020-05-23","kind":"exercise","acquired":true,"shares":7724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired upon vesting of restricted stock units awarded on May 23, 2019."}],"balance_after":13069,"source":{"system":"sec-edgar","filing":"0001209191-20-032212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919120032212/doc4.xml","form_type":"4"}},{"id":3139352,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T01:05:47.000Z","date":"2020-05-19","kind":"grant","acquired":true,"shares":237500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"As a result of a holding company reorganization effective May 19, 2020, Assertio Holdings, Inc., is the successor issuer to Assertio Therapeutics, Inc., pursuant to 12g-3(a) of the Exchange Act."},{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock units that vest in full on the first anniversary of the grant date."}],"balance_after":318090,"source":{"system":"sec-edgar","filing":"0001808665-20-000012","document":"wf-form4_159010952972518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866520000012/wf-form4_159010952972518.xml","form_type":"4"}},{"id":3310624,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-15T23:23:06.000Z","date":"2020-01-13","kind":"sale","acquired":false,"shares":14715,"price":37.4391,"value":550916.3565,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $37.20 to $38.00 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":5345,"source":{"system":"sec-edgar","filing":"0001209191-20-003510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919120003510/doc4.xml","form_type":"4"}},{"id":3310623,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-15T23:23:06.000Z","date":"2020-01-13","kind":"sale","acquired":false,"shares":15285,"price":36.6876,"value":560769.966,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $36.20 to $37.19 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":20060,"source":{"system":"sec-edgar","filing":"0001209191-20-003510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919120003510/doc4.xml","form_type":"4"}},{"id":3513117,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-24T01:20:25.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":12287,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option granted on May 23, 2019, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date."}],"balance_after":12287,"derivative":{"exercise_price":11.6,"exercise_date":"2020-05-23","expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":12287},"source":{"system":"sec-edgar","filing":"0001209191-19-032543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919119032543/doc4.xml","form_type":"4"}},{"id":3513116,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-24T01:20:25.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":7724,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units awarded on May 23, 2019, vests on the first anniversary of the  grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units awarded on May 23, 2019, vests on the first anniversary of the  grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":7724,"derivative":{"underlying":"Common Stock","underlying_shares":7724},"source":{"system":"sec-edgar","filing":"0001209191-19-032543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919119032543/doc4.xml","form_type":"4"}},{"id":3513115,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-24T01:20:25.000Z","date":"2019-05-21","kind":"exercise","acquired":false,"shares":8421,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the restricted stock units vested on May 21, 2019.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"100% of the restricted stock units vested on May 21, 2019.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8421},"source":{"system":"sec-edgar","filing":"0001209191-19-032543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919119032543/doc4.xml","form_type":"4"}},{"id":3513114,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-24T01:20:25.000Z","date":"2019-05-21","kind":"exercise","acquired":true,"shares":8421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired upon vesting of restricted stock units awarded on May 21, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the last date of the reporting person's last ownership report, he transferred 26,925 shares of CCXI common stock pursuant to domestic relations order."}],"balance_after":35345,"source":{"system":"sec-edgar","filing":"0001209191-19-032543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919119032543/doc4.xml","form_type":"4"}},{"id":3533998,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-09T15:31:07.000Z","date":"2019-05-08","kind":"exercise","acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2019-05-08","expiration_date":"2019-05-08","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001005201-19-000078","document":"wf-form4_155741585078890.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520119000078/wf-form4_155741585078890.xml","form_type":"4"}},{"id":3533997,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-09T15:31:07.000Z","date":"2019-05-08","kind":"exercise","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80590,"source":{"system":"sec-edgar","filing":"0001005201-19-000078","document":"wf-form4_155741585078890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520119000078/wf-form4_155741585078890.xml","form_type":"4"}},{"id":3533996,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-09T15:31:07.000Z","date":"2019-05-07","kind":"grant","acquired":true,"shares":39584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the date of the reporting person's last ownership report, he transferred 9,756 shares of the Registrant's common stock pursuant to a domestic relations order. The reporting person no longer reports these securities as beneficially owned by him."}],"balance_after":49340,"source":{"system":"sec-edgar","filing":"0001005201-19-000078","document":"wf-form4_155741585078890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520119000078/wf-form4_155741585078890.xml","form_type":"4"}},{"id":3657699,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-02-14T21:18:03.000Z","date":"2018-05-15","kind":"exercise","acquired":false,"shares":19512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2018-05-15","expiration_date":"2018-05-15","underlying":"Common Stock","underlying_shares":19512},"source":{"system":"sec-edgar","filing":"0001005201-19-000017","document":"wf-form5_155017906904296.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520119000017/wf-form5_155017906904296.xml","form_type":"5"}},{"id":3657698,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-14T21:18:03.000Z","date":"2018-05-15","kind":"exercise","acquired":true,"shares":19512,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9756,"source":{"system":"sec-edgar","filing":"0001005201-19-000017","document":"wf-form5_155017906904296.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520119000017/wf-form5_155017906904296.xml","form_type":"5"}},{"id":3920131,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-05-24T01:51:22.000Z","date":"2018-05-21","kind":"grant","acquired":true,"shares":13352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on May 21, 2018. The award vests and becomes exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued employment or service relationship with the Company on such vesting date."}],"balance_after":13352,"derivative":{"exercise_price":12.94,"expiration_date":"2028-05-21","underlying":"Common Stock","underlying_shares":13352},"source":{"system":"sec-edgar","filing":"0001209191-18-032802","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919118032802/doc4.xml","form_type":"4"}},{"id":3920130,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-24T01:51:22.000Z","date":"2018-05-21","kind":"grant","acquired":true,"shares":8421,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units awarded on May 21, 2018 vests on the first anniversary of the  grant date, subject to the Reporting Person's continued employment or service relationship with the Company on such vesting date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units awarded on May 21, 2018 vests on the first anniversary of the  grant date, subject to the Reporting Person's continued employment or service relationship with the Company on such vesting date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."}],"balance_after":8421,"derivative":{"underlying":"Common Stock","underlying_shares":8421},"source":{"system":"sec-edgar","filing":"0001209191-18-032802","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919118032802/doc4.xml","form_type":"4"}},{"id":3939629,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-11T00:07:02.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock unit awards pursuant to the Company's Non-Employee Director Compensation and Grant Policy."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are scheduled to vest on May 08, 2019, assuming continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are scheduled to vest on May 08, 2019, assuming continued service through the applicable vesting date."}],"balance_after":31250,"derivative":{"underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001179110-18-006585","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911018006585/edgar.xml","form_type":"4"}},{"id":4232989,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-08-16T22:35:54.000Z","date":"2017-08-15","kind":"grant","acquired":true,"shares":19512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock unit awards pursuant to the Company's Non-Employee Director Compensation and Grant Policy."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are scheduled to vest on May 15, 2018, assuming continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are scheduled to vest on May 15, 2018, assuming continued service through the applicable vesting date."}],"balance_after":19512,"derivative":{"underlying":"Common Stock","underlying_shares":19512},"source":{"system":"sec-edgar","filing":"0001179110-17-011570","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911017011570/edgar.xml","form_type":"4"}},{"id":4301017,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-30T23:02:24.000Z","date":"2017-05-26","kind":"exercise","acquired":false,"shares":20362,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the restricted stock units vested on May 26, 2017.  Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"100% of the restricted stock units vested on May 26, 2017.  Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20362},"source":{"system":"sec-edgar","filing":"0001209191-17-036267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919117036267/doc4.xml","form_type":"4"}},{"id":4301016,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T23:02:24.000Z","date":"2017-05-26","kind":"exercise","acquired":true,"shares":20362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were acquired upon vesting of restricted stock units awarded on May 26, 2016."}],"balance_after":53849,"source":{"system":"sec-edgar","filing":"0001209191-17-036267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919117036267/doc4.xml","form_type":"4"}},{"id":4301015,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T23:02:24.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":12912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock was awarded on May 25, 2017, and 100% of the restricted stock will vest on May 25, 2018, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."}],"balance_after":33487,"source":{"system":"sec-edgar","filing":"0001209191-17-036267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324991/000120919117036267/doc4.xml","form_type":"4"}},{"id":4346837,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-24T21:05:48.000Z","date":"2017-04-20","kind":"grant","acquired":true,"shares":19857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). 100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":70554,"source":{"system":"sec-edgar","filing":"0001179110-17-006170","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017006170/edgar.xml","form_type":"4"}},{"id":4577814,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2016-10-19T21:53:22.000Z","date":"2016-10-17","kind":"grant","acquired":true,"shares":18485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options are exercisable in 36 equal monthly installments."}],"balance_after":18485,"derivative":{"exercise_price":23.83,"expiration_date":"2026-10-17","underlying":"Common Stock","underlying_shares":18485},"source":{"system":"sec-edgar","filing":"0001179110-16-030820","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911016030820/edgar.xml","form_type":"4"}},{"id":532406,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-03-04T00:17:19.000Z","date":"2009-02-27","kind":"sale","acquired":false,"shares":500,"price":47.72,"value":23860.0,"ownership":{"direct":true},"balance_after":132176,"source":{"system":"sec-edgar","filing":"0001104659-09-013946","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909013946/a4.xml","form_type":"4"}},{"id":532405,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-03-04T00:17:19.000Z","date":"2009-02-27","kind":"sale","acquired":false,"shares":700,"price":47.71,"value":33397.0,"ownership":{"direct":true},"balance_after":132676,"source":{"system":"sec-edgar","filing":"0001104659-09-013946","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909013946/a4.xml","form_type":"4"}},{"id":532404,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-03-04T00:17:19.000Z","date":"2009-02-27","kind":"sale","acquired":false,"shares":200,"price":47.7005,"value":9540.1,"ownership":{"direct":true},"balance_after":133376,"source":{"system":"sec-edgar","filing":"0001104659-09-013946","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909013946/a4.xml","form_type":"4"}},{"id":532403,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-03-04T00:17:19.000Z","date":"2009-02-27","kind":"sale","acquired":false,"shares":300,"price":47.7,"value":14310.0,"ownership":{"direct":true},"balance_after":133576,"source":{"system":"sec-edgar","filing":"0001104659-09-013946","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909013946/a4.xml","form_type":"4"}},{"id":532402,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-03-04T00:17:19.000Z","date":"2009-02-27","kind":"sale","acquired":false,"shares":1500,"price":47.69,"value":71535.0,"ownership":{"direct":true},"balance_after":133876,"source":{"system":"sec-edgar","filing":"0001104659-09-013946","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909013946/a4.xml","form_type":"4"}},{"id":532401,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-03-04T00:17:19.000Z","date":"2009-02-27","kind":"sale","acquired":false,"shares":200,"price":47.685,"value":9537.0,"ownership":{"direct":true},"balance_after":135376,"source":{"system":"sec-edgar","filing":"0001104659-09-013946","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909013946/a4.xml","form_type":"4"}},{"id":532400,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-03-04T00:17:19.000Z","date":"2009-02-27","kind":"sale","acquired":false,"shares":200,"price":47.6807,"value":9536.14,"ownership":{"direct":true},"balance_after":135576,"source":{"system":"sec-edgar","filing":"0001104659-09-013946","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909013946/a4.xml","form_type":"4"}},{"id":532399,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-03-04T00:17:19.000Z","date":"2009-02-27","kind":"sale","acquired":false,"shares":1300,"price":47.68,"value":61984.0,"ownership":{"direct":true},"balance_after":135776,"source":{"system":"sec-edgar","filing":"0001104659-09-013946","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909013946/a4.xml","form_type":"4"}},{"id":532398,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-03-04T00:17:19.000Z","date":"2009-02-27","kind":"sale","acquired":false,"shares":5554,"price":47.67,"value":264759.18,"ownership":{"direct":true},"balance_after":137076,"source":{"system":"sec-edgar","filing":"0001104659-09-013946","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909013946/a4.xml","form_type":"4"}},{"id":532397,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-03-04T00:17:19.000Z","date":"2009-02-27","kind":"tax_withholding","acquired":false,"shares":6813,"price":50.58,"value":344601.54,"ownership":{"direct":true},"balance_after":142630,"source":{"system":"sec-edgar","filing":"0001104659-09-013946","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909013946/a4.xml","form_type":"4"}},{"id":532847,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2009-02-24T22:05:02.000Z","date":"2009-02-20","kind":"grant","acquired":true,"shares":64900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.  The option becomes exercisable in annual increments of 21,634 on 02/20/2010, 21,633 on 02/20/2011, and 21,633 on 02/20/2012."}],"balance_after":64900,"derivative":{"exercise_price":54.14,"exercise_date":"2010-02-20","expiration_date":"2019-02-19","underlying":"Common shares","underlying_shares":64900},"source":{"system":"sec-edgar","filing":"0001104659-09-011818","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909011818/a4.xml","form_type":"4"}},{"id":532846,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-24T22:05:02.000Z","date":"2009-02-20","kind":"grant","acquired":true,"shares":45800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":149443,"source":{"system":"sec-edgar","filing":"0001104659-09-011818","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909011818/a4.xml","form_type":"4"}},{"id":532997,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-19T17:16:34.000Z","date":"2009-02-17","kind":"sale","acquired":false,"shares":4661,"price":54.092,"value":252122.812,"ownership":{"direct":true},"balance_after":103643,"source":{"system":"sec-edgar","filing":"0001104659-09-010665","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010665/a4.xml","form_type":"4"}},{"id":532996,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-19T17:16:34.000Z","date":"2009-02-17","kind":"sale","acquired":false,"shares":904,"price":54.101,"value":48907.304,"ownership":{"direct":true},"balance_after":108304,"source":{"system":"sec-edgar","filing":"0001104659-09-010665","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010665/a4.xml","form_type":"4"}},{"id":532995,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-19T17:16:34.000Z","date":"2009-02-17","kind":"tax_withholding","acquired":false,"shares":3268,"price":54.94,"value":179543.92,"ownership":{"direct":true},"balance_after":109208,"source":{"system":"sec-edgar","filing":"0001104659-09-010665","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010665/a4.xml","form_type":"4"}},{"id":533073,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-18T22:00:16.000Z","date":"2009-02-02","kind":"exercise","acquired":true,"shares":32642,"price":46.34,"value":1512630.28,"ownership":{"direct":true},"balance_after":112476,"source":{"system":"sec-edgar","filing":"0001104659-09-010511","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010511/a4a.xml","form_type":"4/A","original_submission_date":"2009-02-04"}},{"id":533072,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-18T22:00:16.000Z","date":"2009-02-02","kind":"exercise","acquired":true,"shares":10856,"price":54.54,"value":592086.24,"ownership":{"direct":true},"balance_after":79834,"source":{"system":"sec-edgar","filing":"0001104659-09-010511","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010511/a4a.xml","form_type":"4/A","original_submission_date":"2009-02-04"}},{"id":533071,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-18T22:00:16.000Z","date":"2009-02-02","kind":"exercise","acquired":true,"shares":55333,"price":44.16,"value":2443505.28,"ownership":{"direct":true},"balance_after":68978,"source":{"system":"sec-edgar","filing":"0001104659-09-010511","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010511/a4a.xml","form_type":"4/A","original_submission_date":"2009-02-04"}},{"id":533070,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-18T22:00:16.000Z","date":"2009-02-02","kind":"sale","acquired":false,"shares":1500,"price":55.34,"value":83010.0,"ownership":{"direct":true},"balance_after":13645,"source":{"system":"sec-edgar","filing":"0001104659-09-010511","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010511/a4a.xml","form_type":"4/A","original_submission_date":"2009-02-04"}},{"id":533069,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-18T22:00:16.000Z","date":"2009-02-02","kind":"sale","acquired":false,"shares":5300,"price":55.33,"value":293249.0,"ownership":{"direct":true},"balance_after":15145,"source":{"system":"sec-edgar","filing":"0001104659-09-010511","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010511/a4a.xml","form_type":"4/A","original_submission_date":"2009-02-04"}},{"id":533068,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-18T22:00:16.000Z","date":"2009-02-02","kind":"sale","acquired":false,"shares":1642,"price":55.32,"value":90835.44,"ownership":{"direct":true},"balance_after":20445,"source":{"system":"sec-edgar","filing":"0001104659-09-010511","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010511/a4a.xml","form_type":"4/A","original_submission_date":"2009-02-04"}},{"id":533067,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-18T22:00:16.000Z","date":"2009-02-02","kind":"sale","acquired":false,"shares":1000,"price":55.3,"value":55300.0,"ownership":{"direct":true},"balance_after":22087,"source":{"system":"sec-edgar","filing":"0001104659-09-010511","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010511/a4a.xml","form_type":"4/A","original_submission_date":"2009-02-04"}},{"id":533066,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-18T22:00:16.000Z","date":"2009-02-02","kind":"sale","acquired":false,"shares":3000,"price":55.29,"value":165870.0,"ownership":{"direct":true},"balance_after":23087,"source":{"system":"sec-edgar","filing":"0001104659-09-010511","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010511/a4a.xml","form_type":"4/A","original_submission_date":"2009-02-04"}},{"id":533065,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-18T22:00:16.000Z","date":"2009-02-02","kind":"sale","acquired":false,"shares":3100,"price":55.28,"value":171368.0,"ownership":{"direct":true},"balance_after":26087,"source":{"system":"sec-edgar","filing":"0001104659-09-010511","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010511/a4a.xml","form_type":"4/A","original_submission_date":"2009-02-04"}},{"id":533064,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-18T22:00:16.000Z","date":"2009-02-02","kind":"sale","acquired":false,"shares":1200,"price":55.27,"value":66324.0,"ownership":{"direct":true},"balance_after":29187,"source":{"system":"sec-edgar","filing":"0001104659-09-010511","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010511/a4a.xml","form_type":"4/A","original_submission_date":"2009-02-04"}},{"id":533063,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2009-02-18T22:00:16.000Z","date":"2009-02-02","kind":"sale","acquired":false,"shares":1500,"price":55.26,"value":82890.0,"ownership":{"direct":true},"balance_after":30387,"source":{"system":"sec-edgar","filing":"0001104659-09-010511","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465909010511/a4a.xml","form_type":"4/A","original_submission_date":"2009-02-04"}}],"next_cursor":"2009-02-18T22:00:16.000000Z,533063"}